WHAT IS THE POTENTIAL OF CZECH VERSION OF THE FACE-NAME ASSOCIATIVE MEMORY EXAM (CZ-FNAME-12) FOR ASSESSING MEMORY DEFICIT?

Associative memory is impaired early in Alzheimer's disease (AD). We adapted a challenging associative memory test, a short form of the Face-Name Associative Memory Exam (CZ-FNAME-12). We hypothesized that the CZ-FNAME-12 would differentiate between patients with amnestic mild cognitive impairment (aMCI) and cognitively normal elderly (CN). Next, we hypothesized that the CZ-FNAME-12 would not show a ceiling effect in CN. Twenty-four patients with aMCI (mean MMSE = 27.71±1.33, mean age = 75±4.56) and twenty-four matched CN (28.79±.98, 73.71±4.49) from the Czech Brain Aging Study were defined by comprehensive neuropsychological battery including Rey auditory verbal learning test (RAVLT) and logical memory test (LMT-I). After that, all of them underwent the experimental CZ-FNAME-12. There were significant differences between the aMCI and CN groups in the CZ-FNAME-12 scores: 30-minute delay cued recall of names (p = .001; Cohen's d = .92), 30-minute delay cued recall of occupations (p